Skip to content
Every compound links to batch-tested stock at Nordapep, with a Certificate of Analysis per batch.
peptide.wiki

Tirzepatide vs Mazdutide

Both are dual agonists and both act on the GLP-1 receptor. The difference is the second receptor: tirzepatide adds GIP-receptor activity on a GIP-based backbone, while mazdutide adds glucagon-receptor activity on an oxyntomodulin-based backbone. Both came out of Eli Lilly's incretin research; mazdutide was then developed in China by Innovent Biologics.

Edited by Alex James, Founder and editor

Dual GIP and GLP-1 receptor agonist

Choose Tirzepatide if

  • ✓ You need an approved, widely characterised dual-agonist reference
  • ✓ Your question is about GIP-receptor signalling alongside GLP-1
Browse Nordapep

GLP-1 and glucagon receptor dual agonist, approved in China

Choose Mazdutide if

  • ✓ Your question is about glucagon-receptor activity alongside GLP-1
  • ✓ You are studying oxyntomodulin analogues
Browse Nordapep

Side-by-side specification

CompareTirzepatide
Dual GIP and GLP-1 receptor agonist
Mazdutide
GLP-1 and glucagon receptor dual agonist, approved in China
ClassDual GIP / GLP-1 receptor agonistDual GLP-1 / glucagon receptor agonist (oxyntomodulin analogue)
Research areaMetabolicMetabolic
Receptor targetsGIPR, GLP-1RGLP-1R, GCGR
Length39 amino acids (acylated)Modified oxyntomodulin-based peptide (fatty-acid conjugated)
Molecular mass≈ 4.81 kDaNot fully published (large acylated peptide, several kDa)
OriginSynthetic, GIP-based sequenceSynthetic, oxyntomodulin-based sequence
Evidence level
5/5
Approved drug, phase 3 trials
4/5
Late-stage human trials
Regulatory statusApproved prescription medicineApproved in China
Nordapep from——
Best price per mg——
Browse Nordapep →Browse Nordapep →

What separates them

Tirzepatide is approved by the MHRA, EMA and FDA and rated 5. Mazdutide was approved in China in 2025 but nowhere else, and is rated 4, with human data mostly from Chinese study populations. We are not aware of a published head-to-head trial between the two.

Read the full guides for Tirzepatide and Mazdutide, or add a third compound in the comparison tool.

Studying both?
Nordapep lists each with its own batch CoA. Its research stacks bundle common pairings.
See stacks at Nordapep

FAQ

Do tirzepatide and mazdutide hit the same receptors?

They share one. Both activate the GLP-1 receptor; tirzepatide also activates the GIP receptor, and mazdutide also activates the glucagon receptor.

Is mazdutide approved outside China?

No. As of November 2026 it is approved by China's NMPA only. Tirzepatide is approved in the UK, EU and US. Research-grade material of either is for in vitro laboratory work only.

Are Tirzepatide and Mazdutide approved medicines?

Tirzepatide: Approved prescription medicine. Mazdutide: Approved in China. Research-grade material of either is not a medicine and is supplied for in vitro research only.

Where can I buy Tirzepatide and Mazdutide?

Nordapep lists compounds with a Certificate of Analysis matched to the batch reference. Check each compound page for current availability.

More comparisons

For laboratory research only. Nothing on peptide.wiki is medical advice. The compounds described are not for human or veterinary use, and research-grade material is not a medicine.